Zhang L, Feng YL, Wang YS and Yang SL: Modern research status on Evodia rutaecarpa. J Jiangxi Univ Tradit Chin Med. 22(5)2010.

Nam EY, Kim SA, Kim H, Kim SH, Han JH, Lee JH and Kim DI: Akt activation by Evodiae fructus extract protects ovary against 4-vinylcyclohexene diepoxide-induced ovotoxicity. J Ethnopharmacol. 194:733–739. 2016.PubMed/NCBI View Article : Google Scholar

Sui H, Liu X, Jin BH, Pan SF, Zhou LH, Yu NA, Wu J, Cai JF, Fan ZZ, Zhu HR and Li Q: Zuo Jin Wan, a traditional Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo. Evid Based Complement Alternat Med. 2013(957078)2013.PubMed/NCBI View Article : Google Scholar

Pan J, Xu Y, Song H, Zhou X, Yao Z and Ji G: Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells. BMC Complement Altern Med. 17(506)2017.PubMed/NCBI View Article : Google Scholar

Tang QF, Ji Q, Qiu YY, Cao AL, Chi YF, Liang B, Peng W and Yin PH: Synergistic effect of Zuo Jin Wan on DDP-induced apoptosis in human gastric cancer SGC-7901/DDP cells. Evid Based Complement Alternat Med. 2014(724764)2014.PubMed/NCBI View Article : Google Scholar

Guan X, Zheng X, Vong CT, Zhao J, Xiao J, Wang Y and Zhong Z: Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro. Eur J Pharmacol. 875(173031)2020.PubMed/NCBI View Article : Google Scholar

Chou ST, Hsiang CY, Lo HY, Huang HF, Lai MT, Hsieh CL, Chiang SY and Ho TY: Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice. BMC Complement Altern Med. 17(121)2017.PubMed/NCBI View Article : Google Scholar

Bae JR, Park WH, Suh DH, No JH, Kim YB and Kim K: Role of limonin in anticancer effects of evodia rutaecarpa on ovarian cancer cells. BMC Complement Med Ther. 20(94)2020.PubMed/NCBI View Article : Google Scholar

Park E, Lee MY, Seo CS, Jang JH, Kim YU and Shin HK: Ethanol extract of evodia rutaecarpa attenuates cell growth through caspase-dependent apoptosis in benign prostatic hyperplasia-1 cells. Nutrients. 10(523)2018.PubMed/NCBI View Article : Google Scholar

Gong X, Zhou X, Cai Z, Zhang J and Zhou W: Studies on chemical constituents of Evodia rutaecarpa. Zhongguo Zhong Yao Za Zhi. 34:177–179. 2009.PubMed/NCBI(In Chinese).

Kim D, Lee YH, Park SH, Lee MJ, Kim MJ, Jang HS, Lee JM, Lee HY, Han BS, Son WC, et al: Subchronic oral toxicity of evodia fruit powder in rats. J Ethnopharmacol. 151:1072–1078. 2014.PubMed/NCBI View Article : Google Scholar

Hu X, Li D, Chu C, Li X, Wang X, Jia Y, Hua H and Xu F: Antiproliferative effects of alkaloid evodiamine and its derivatives. Int J Mol Sci. 19(3403)2018.PubMed/NCBI View Article : Google Scholar

Wu JY, Chang MC, Chen CS, Lin HC, Tsai HP, Yang CC, Yang CH and Lin CM: Topoisomerase I inhibitor evodiamine acts as an antibacterial agent against drug-resistant Klebsiella pneumoniae. Planta Med. 79:27–29. 2013.PubMed/NCBI View Article : Google Scholar

Peng J and Li YJ: The vanilloid receptor TRPV1: Role in cardiovascular and gastrointestinal protection. Eur J Pharmacol. 627:1–7. 2010.PubMed/NCBI View Article : Google Scholar

Zhao Z, Gong S, Wang S and Ma C: Effect and mechanism of evodiamine against ethanol-induced gastric ulcer in mice by suppressing Rho/NF-κB pathway. Int Immunopharmacol. 28:588–595. 2015.PubMed/NCBI View Article : Google Scholar

Yu H, Jin H, Gong W, Wang Z and Liang H: Pharmacological actions of multi-target-directed evodiamine. Molecules. 18:1826–1843. 2013.PubMed/NCBI View Article : Google Scholar

Yuan SM, Gao K, Wang DM, Quan XZ, Liu JN, Ma CM, Qin C and Zhang LF: Evodiamine improves congnitive abilities in SAMP8 and APP(swe)/PS1(ΔE9) transgenic mouse models of Alzheimer's disease. Acta Pharmacol Sin. 32:295–302. 2011.PubMed/NCBI View Article : Google Scholar

Pan X, Hartley JM, Hartley JA, White KN, Wang Z and Bligh SW: Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells. Phytomedicine. 19:618–624. 2012.PubMed/NCBI View Article : Google Scholar

Huang J, Chen ZH, Ren CM, Wang DX, Yuan SX, Wu QX, Chen QZ, Zeng YH, Shao Y, Li Y, et al: Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation. Oncol Rep. 34:3203–3211. 2015.PubMed/NCBI View Article : Google Scholar

Zhong ZF, Tan W, Wang SP, Qiang WA and Wang YT: Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells. Sci Rep. 5(16415)2015.PubMed/NCBI View Article : Google Scholar

Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q and Cao P: Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett. 328:243–251. 2013.PubMed/NCBI View Article : Google Scholar

Wei J, Ching LC, Zhao JF, Shyue SK, Lee HF, Kou YR and Lee TS: Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis. Acta Physiol (Oxf). 207:299–307. 2013.PubMed/NCBI View Article : Google Scholar

Wanner SP, Garami A, Pakai E, Oliveira DL, Gavva NR, Coimbra CC and Romanovsky AA: Aging reverses the role of the transient receptor potential vanilloid-1 channel in systemic inflammation from anti-inflammatory to proinflammatory. Cell Cycle. 11:343–349. 2012.PubMed/NCBI View Article : Google Scholar

Mezrich JD, Nguyen LP, Kennedy G, Nukaya M, Fechner JH, Zhang X, Xing Y and Bradfield CA: SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. PLoS One. 7(e44547)2012.PubMed/NCBI View Article : Google Scholar

O'Donnell EF, Kopparapu PR, Koch DC, Jang HS, Phillips JL, Tanguay RL, Kerkvliet NI and Kolluri SK: The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells. PLoS One. 7(e40926)2012.PubMed/NCBI View Article : Google Scholar

Shyr MH, Lin LC, Lin TY and Acta TH: Determination and pharmacokinetics of evodiamine in the plasma and feces of conscious rats. Anal Chim Acta. 558:16–21. 2006.

Lefrak EA, Pitha J, Rosenheim S and Gottlieb JA: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 32:302–314. 1973.PubMed/NCBI View Article : Google Scholar

Olson RD, Mushlin PS, Brenner DE, Fleischer S, Cusack BJ, Chang BK and Boucek RJ Jr: Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci USA. 85:3585–3589. 1988.PubMed/NCBI View Article : Google Scholar

Stewart DJ, Grewaal D, Green RM, Mikhael N, Goel R, Montpetit VA and Redmond MD: Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues. Anticancer Res. 13:1945–1952. 1993.PubMed/NCBI

Yang W, Ma L, Li S, Cui K, Lei L and Ye Z: Evaluation of the cardiotoxicity of evodiamine in vitro and in vivo. Molecules. 22(943)2017.PubMed/NCBI View Article : Google Scholar

Huang W, Zhao Y and Sun R: Comparative study on acute toxicity of different components of Evodia rutaecarpa in mice. Zhongguo Yao Wu Jing Jie. 7:129–134. 2010.

Li F, Dong YZ, Zhang D, Zhang XM, Lin ZJ and Zhang B: Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments. PLoS One. 14(e0216948)2019.PubMed/NCBI View Article : Google Scholar

Yan S, Liu Y, Feng J, Zhao H, Yu Z, Zhao J, Li Y and Zhang J: Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines. Drug Metab Rev. 50:140–160. 2018.PubMed/NCBI View Article : Google Scholar

Wen B, Roongta V, Liu L and Moore DJ: Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: Dehydrogenation and inactivation of cytochrome P450 3A4. Drug Metab Dispos. 42:1044–1054. 2014.PubMed/NCBI View Article : Google Scholar

Wang C, Yue F, Ai G and Yang J: Simultaneous determination of evodiamine and its four metabolites in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr. 32(e4219)2018.PubMed/NCBI View Article : Google Scholar

Li L, Liu R, Ye M, Hu X, Qiao W, Bi K and Guo D: Microbial metabolism of evodiamine by penicillium janthinellum and its application for metabolite identification in rat urine. Enzyme Microb Technol. 39:561–567. 2006.

Jiang J and Hu C: Evodiamine: A novel anti-cancer alkaloid from evodia rutaecarpa. Molecules. 14:1852–1859. 2009.PubMed/NCBI View Article : Google Scholar

Ogasawara M, Matsunaga T, Takahashi S, Saiki I and Suzuki H: Anti-invasive and metastatic activities of evodiamine. Biol Pharm Bull. 25:1491–1493. 2002.PubMed/NCBI View Article : Google Scholar

Chien CC, Wu MS, Shen SC, Ko CH, Chen CH, Yang LL and Chen YC: Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: A structure-activity study of evodiamine. PLoS One. 9(e99729)2014.PubMed/NCBI View Article : Google Scholar

Rao L and White E: Bcl-2 and the ICE family of apoptotic regulators: Making a connection. Curr Opin Genet Dev. 7:52–58. 1997.PubMed/NCBI View Article : Google Scholar

Zou Y, Qin X, Xiong H, Zhu F, Chen T and Wu H: Apoptosis of human non-small-cell lung cancer A549 cells triggered by evodiamine through MTDH-dependent signaling pathway. Tumour Biol. 36:5187–5193. 2015.PubMed/NCBI View Article : Google Scholar

Zhu LH, Bi W, Liu XD, Li JF, Wu YY, Du BY and Tan YH: Induction of apoptosis by evodiamine involves both activation of mitotic arrest and mitotic slippage. Oncol Rep. 26:1447–1455. 2011.PubMed/NCBI View Article : Google Scholar

Lee TJ, Kim EJ, Kim S, Jung EM, Park JW, Jeong SH, Park SE, Yoo YH and Kwon TK: Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol Cancer Ther. 5:2398–2407. 2006.PubMed/NCBI View Article : Google Scholar

Fei XF, Wang BX, Li TJ, Tashiro S, Minami M, Xing DJ and Ikejima T: Evodiamine, a constituent of Evodiae fructus, induces anti-proliferating effects in tumor cells. Cancer Sci. 94:92–98. 2003.PubMed/NCBI View Article : Google Scholar

Zhang Y, Wu LJ, Tashiro S, Onodera S and Ikejima T: Intracellular regulation of evodiamine-induced A375-S2 cell death. Biol Pharm Bull. 26:1543–1547. 2003.PubMed/NCBI View Article : Google Scholar

Liu X, Yang L, Bi Y, Wang LH and Huang H: Effect of evodiamine in inducing apoptosis of gastric cancer SGC-7901 cells through mTOR signal pathway. Zhongguo Zhong Yao Za Zhi. 40:3262–3266. 2015.PubMed/NCBI(In Chinese).

Yang F, Shi L, Liang T, Ji L, Zhang G, Shen Y, Zhu F and Xu L: Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma. Biochem Biophys Res Commun. 485:54–61. 2017.PubMed/NCBI View Article : Google Scholar

Guo XX, Li XP, Zhou P, Li DY, Lyu XT, Chen Y, Lyu YW, Tian K, Yuan DZ, Ran JH, et al: Evodiamine induces apoptosis in SMMC-7721 and HepG2 cells by suppressing NOD1 signal pathway. Int J Mol Sci. 19(3419)2018.PubMed/NCBI View Article : Google Scholar

Zhang C, Fan X, Xu X, Yang X, Wang X and Liang HP: Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells. Anticancer Drugs. 21:766–776. 2010.PubMed/NCBI View Article : Google Scholar

Yang L, Liu X, Wu D, Zhang M, Ran G, Bi Y and Huang H: Growth inhibition and induction of apoptosis in SGC-7901 human gastric cancer cells by evodiamine. Mol Med Rep. 9:1147–1152. 2014.PubMed/NCBI View Article : Google Scholar

Zhu B, Zhao L, Liu Y, Jin Y, Feng J, Zhao F, Sun J, Geng R and Wei Y: Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma. Int J Biochem Cell Biol. 108:98–110. 2019.PubMed/NCBI View Article : Google Scholar

Yang J, Wu LJ, Tashino S, Onodera S and Ikejima T: Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis. Free Radic Res. 41:1099–1108. 2007.PubMed/NCBI View Article : Google Scholar

Yang J, Wu LJ, Tashino S, Onodera S and Ikejima T: Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res. 42:492–504. 2008.PubMed/NCBI View Article : Google Scholar

Wei WT, Chen H, Wang ZH, Ni ZL, Liu HB, Tong HF, Guo HC, Liu DL and Lin SZ: Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Int J Biol Sci. 8:1–14. 2012.PubMed/NCBI View Article : Google Scholar

Hong Z, Wang Z, Zhou B, Wang J, Tong H, Liao Y, Zheng P, Jamshed MB, Zhang Q and Chen H: Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. Int J Oncol. 56:783–793. 2020.PubMed/NCBI View Article : Google Scholar

Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y and Zhi F: Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. Onco Targets Ther. 11:1183–1192. 2018.PubMed/NCBI View Article : Google Scholar

Wang C, Li S and Wang MW: Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol In Vitro. 24:898–904. 2010.PubMed/NCBI View Article : Google Scholar

Wang C, Wang MW, Tashiro S, Onodera S and Ikejima T: Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death. J Pharmacol Sci. 97:494–500. 2005.PubMed/NCBI View Article : Google Scholar

Huang DM, Guh JH, Huang YT, Chueh SC, Chiang PC and Teng CM: Induction of mitotic arrest and apoptosis in human prostate cancer pc-3 cells by evodiamine. J Urol. 173:256–261. 2005.PubMed/NCBI View Article : Google Scholar

Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ and Wang PS: Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem. 101:44–56. 2007.PubMed/NCBI View Article : Google Scholar

Kan SF, Huang WJ, Lin LC and Wang PS: Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int J Cancer. 110:641–651. 2004.PubMed/NCBI View Article : Google Scholar

Liao CH, Pan SL, Guh JH, Chang YL, Pai HC, Lin CH and Teng CM: Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis. 26:968–975. 2005.PubMed/NCBI View Article : Google Scholar

Rasul A, Yu B, Zhong L, Khan M, Yang H and Ma T: Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. Oncol Rep. 27:1481–1487. 2012.PubMed/NCBI View Article : Google Scholar

Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM and Piwnica-Worms H: The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem. 275:5600–5605. 2000.PubMed/NCBI View Article : Google Scholar

Devault A, Martinez AM, Fesquet D, Labbé JC, Morin N, Tassan JP, Nigg EA, Cavadore JC and Dorée M: MAT1 (‘menage à trois’) a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J. 14:5027–5036. 1995.PubMed/NCBI

Sun C, Zhang G, Luan S, Luan C, Shao H, Dong F and Liu X: Evodiamine inhibits the proliferation of leukemia cell line K562 by regulating peroxisome proliferators-activated receptor gamma (PPARγ) pathway. J Recept Signal Transduct Res. 36:422–428. 2016.PubMed/NCBI View Article : Google Scholar

Moosavi F, Giovannetti E, Saso L and Firuzi O: HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers. Crit Rev Clin Lab Sci. 56:533–566. 2019.PubMed/NCBI View Article : Google Scholar

Ogasawara M and Suzuki H: Inhibition by evodiamine of hepatocyte growth factor-induced invasion and migration of tumor cells. Biol Pharm Bull. 27:578–582. 2004.PubMed/NCBI View Article : Google Scholar

Peng X, Zhang Q, Zeng Y, Li J, Wang L and Ai P: Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression. Cancer Chemother Pharmacol. 76:1173–1184. 2015.PubMed/NCBI View Article : Google Scholar

Zhou P, Li XP, Jiang R, Chen Y, Lv XT, Guo XX, Tian K, Yuan DZ, Lv YW, Ran JH, et al: Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer. Anticancer Drugs. 30:611–617. 2019.PubMed/NCBI View Article : Google Scholar

Shi L, Yang F, Luo F, Liu Y, Zhang F, Zou M and Liu Q: Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis. Tumour Biol. 37:12791–12803. 2016.PubMed/NCBI View Article : Google Scholar

Shyu KG, Lin S, Lee CC, Chen E, Lin LC, Wang BW and Tsai SC: Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity. Life Sci. 78:2234–2243. 2006.PubMed/NCBI View Article : Google Scholar

Takada Y, Kobayashi Y and Aggarwal BB: Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem. 280:17203–17212. 2005.PubMed/NCBI View Article : Google Scholar

Li YL, Zhang NY, Hu X, Chen JL, Rao MJ, Wu LW, Li QY, Zhang B, Yan W and Zhang C: Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia. Biochem Biophys Res Commun. 498:481–486. 2018.PubMed/NCBI View Article : Google Scholar

Li FS, Huang J, Cui MZ, Zeng JR, Li PP, Li L, Deng Y, Hu Y, He BC and Shu DZ: BMP9 mediates the anticancer activity of evodiamine through HIF-1α/p53 in human colon cancer cells. Oncol Rep. 43:415–426. 2020.PubMed/NCBI View Article : Google Scholar

Kim H, Yu Y, Choi S, Lee H, Yu J, Lee JH and Kim WY: Evodiamine eliminates colon cancer stem cells via suppressing notch and Wnt signaling. Molecules. 24(4520)2019.PubMed/NCBI View Article : Google Scholar

Wen Z, Feng S, Wei L, Wang Z, Hong D and Wang Q: Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells. Int J Mol Med. 36:1657–1663. 2015.PubMed/NCBI View Article : Google Scholar

Yang X, Zhang Y, Huang Y, Wang Y, Qi X, Su T and Lu L: Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases. Phytomedicine. 68(153176)2020.PubMed/NCBI View Article : Google Scholar

Su T, Yang X, Deng JH, Huang QJ, Huang SC, Zhang YM, Zheng HM, Wang Y, Lu LL and Liu ZQ: Evodiamine, a novel NOTCH3 methylation stimulator, significantly suppresses lung carcinogenesis in vitro and in vivo. Front Pharmacol. 9(434)2018.PubMed/NCBI View Article : Google Scholar

Gai L, Rao GX, Song CQ and Hu ZB: Studies on the chemical constituents of evodia rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang. Yao Xue Xue Bao. 36:743–745. 2001.PubMed/NCBI(In Chinese).

Xu S, Peng J, Li Y, He L, Chen F, Zhang J and Ding J: Pharmacokinetic comparisons of rutaecarpine and evodiamine after oral administration of Wu-Chu-Yu extracts with different purities to rats. J Ethnopharmacol. 139:395–400. 2012.PubMed/NCBI View Article : Google Scholar

Lin C, Pan X, Li W, Ma J, Pan J, Cai J, Wang X and Lin G: Simultaneous determination of evodiamine and rutecarpine in rabbit plasma by LC-ESI-MS and its application to pharmacokinetics. Pharmazie. 66:920–923. 2011.PubMed/NCBI

Xia YY, Xu HY, Cai YY, Si DY and Liu CX: Simultaneous determination of evodiamine and evodine in beagle dog plasma using liquid chromatography tandem mass spectrometry. J Asian Nat Prod Res. 15:235–243. 2013.PubMed/NCBI View Article : Google Scholar

Komatsu K, Wakame K and Kano Y: Pharmacological properties of galenical preparation. XVI. Pharmacokinetics of evodiamine and the metabolite in rats. Biol Pharm Bull. 16:935–938. 1993.PubMed/NCBI View Article : Google Scholar

Jeng KF, Lin YH, Lin LC, Chou CJ, Tsai TH and Chen CF: High-performance liquid chromatographic determination of evodiamine in rat plasma: Application to pharmacokinetic studies. J Chromatogr B Biomed Appl. 668:343–345. 1995.PubMed/NCBI View Article : Google Scholar

Xu H, Li Q, Yin Y, Lv C, Sun W, He B, Liu R, Chen X and Bi K: Simultaneous determination of three alkaloids, four ginsenosides and limonin in the plasma of normal and headache rats after oral administration of Wu-Zhu-Yu decoction by a novel ultra fast liquid chromatography-tandem mass spectrometry method: Application to a comparative pharmacokinetics and ethological study. J Mass Spectrom. 48:519–532. 2013.PubMed/NCBI View Article : Google Scholar

Sun HZ, Fang ZZ, Cao YF, Sun XY and Hong M: Investigation of the in vitro metabolism of evodiamine: Characterization of metabolites and involved cytochrome p450 isoforms. Phytother Res. 27:705–712. 2013.PubMed/NCBI View Article : Google Scholar

Zhang Z, Fang T, Zhou H, Yuan J and Liu Q: Characterization of the in vitro metabolic profile of evodiamine in human liver microsomes and hepatocytes by UHPLC-Q exactive mass spectrometer. Front Pharmacol. 9(130)2018.PubMed/NCBI View Article : Google Scholar

Zhang YT, Zhang DF, Ge NY, Zhu GH, Hao C, Zhang Y and Chen RJ: Effect of evodiamine on CYP enzymes in rats by a cocktail method. Pharmacology. 97:218–223. 2016.PubMed/NCBI View Article : Google Scholar

Xu H, Zhang T, Yang H, Xiao X, Bian Y, Si D and Liu C: Preparation of evodiamine solid dispersions and its pharmacokinetics. Indian J Pharm Sci. 73:276–281. 2011.PubMed/NCBI View Article : Google Scholar

Tan Q, Liu S, Chen X, Wu M, Wang H, Yin H, He D, Xiong H and Zhang J: Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech. 13:534–547. 2012.PubMed/NCBI View Article : Google Scholar

Grattagliano I, Diogo CV, Mastrodonato M, de Bari O, Persichella M, Wang DQ, Liquori A, Ferri D, Carratù MR, Oliveira PJ and Portincasa P: A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. World J Gastroenterol. 19:3007–3017. 2013.PubMed/NCBI View Article : Google Scholar

Hu J, Chen D, Jiang R, Tan Q, Zhu B and Zhang J: Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine-phospholipid nanocomplex. Int J Nanomedicine. 9:4411–4420. 2014.PubMed/NCBI View Article : Google Scholar

Zhao J, Liu S, Hu X, Zhang Y, Yan S, Zhao H, Zeng M, Li Y, Yang L and Zhang J: Improved delivery of natural alkaloids into lung cancer through woody oil-based emulsive nanosystems. Drug Deliv. 25:1426–1437. 2018.PubMed/NCBI View Article : Google Scholar

Zhang X, Liu HM, Lei TT, Feng J and Zhang JQ: A preliminary study of pharmacokinetics of evodiamine hydroxypropyl-β-cyclodextrin inclusion complex. Nan Fang Yi Ke Da Xue Xue Bao. 36:548–551. 2016.PubMed/NCBI(In Chinese).

Qiu C, Gao LN, Yan K, Cui YL and Zhang Y: A promising antitumor activity of evodiamine incorporated in hydroxypropyl-β-cyclodextrin: Pro-apoptotic activity in human hepatoma HepG2 cells. Chem Cent J. 10(46)2016.PubMed/NCBI View Article : Google Scholar

Xu L, Li W, Sadeghi-Soureh S, Amirsaadat S, Pourpirali R and Alijani S: Dual drug release mechanisms through mesoporous silica nanoparticle/electrospun nanofiber for enhanced anticancer efficiency of curcumin. J Biomed Mater Res A, Aug 10, 2021 (Online ahead of print).

Rastegari E, Hsiao YJ, Lai WY, Lai YH, Yang TC, Chen SJ, Huang PI, Chiou SH, Mou CY and Chien Y: An update on mesoporous silica nanoparticle applications in nanomedicine. Pharmaceutics. 13(1067)2021.PubMed/NCBI View Article : Google Scholar

Feng Y, Li NX, Yin HL, Chen TY, Yang Q and Wu M: Thermo- and pH-responsive, lipid-coated, mesoporous silica nanoparticle-based dual drug delivery system to improve the antitumor effect of hydrophobic drugs. Mol Pharm. 16:422–436. 2019.PubMed/NCBI View Article : Google Scholar

Zou L, Chen F, Bao J, Wang S, Wang L, Chen M, He C and Wang Y: Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles. Drug Deliv. 23:908–916. 2016.PubMed/NCBI View Article : Google Scholar

Li C, Cai G, Song D, Gao R, Teng P, Zhou L, Ji Q, Sui H, Cai J, Li Q and Wang Y: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer. Biomater Sci. 7:3627–3639. 2019.PubMed/NCBI View Article : Google Scholar

Ge Y, Zhao Y and Li L: Preparation of sodium cholate-based micelles through non-covalent ıbonding interaction and application as oral delivery systems for paclitaxel. Drug Deliv. 23:2555–2565. 2016.PubMed/NCBI View Article : Google Scholar

Zhang J, Li Y, Fang X, Zhou D, Wang Y and Chen M: TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Int J Pharm. 476:185–198. 2014.PubMed/NCBI View Article : Google Scholar

Chen F, Zhang J, He Y, Fang X, Wang Y and Chen M: Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Biomater Sci. 4:167–182. 2016.PubMed/NCBI View Article : Google Scholar

Jiang J, Liu Y, Wu C, Qiu Y, Xu X, Lv H, Bai A and Liu X: Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells. Drug Dev Ind Pharm. 43:1304–1313. 2017.PubMed/NCBI View Article : Google Scholar

Wu S, Pan H, Tan S, Ding C, Huang G, Liu G, Guo J and Su Z: In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres (CCMS). Food Nutr Res. 61(1331658)2017.PubMed/NCBI View Article : Google Scholar

Wang S, Wang L, Shi Z, Zhong Z, Chen M and Wang Y: Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein. PLoS One. 9(e97512)2014.PubMed/NCBI View Article : Google Scholar

Li YL, Pan YN, Wu WJ, Mao SY, Sun J, Zhao YM, Dong JY, Zhang DY, Pan JP, Zhang C and Lin NM: Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition. Med Oncol. 33(16)2016.PubMed/NCBI View Article : Google Scholar

Pan X, Wang M, Wu Y, Lu X, Shang Y, Xu Y, Zhai Y, Li J, Li Z and Gong M: Identification of active ingredients in Wuzhuyu decoction improving migraine in mice by spectral efficiency association. Mol Med Rep. 12:1524–1534. 2015.PubMed/NCBI View Article : Google Scholar

Xu H, Niu H, He B, Cui C, Li Q and Bi K: Comprehensive qualitative ingredient profiling of chinese herbal formula Wu-Zhu-Yu decoction via a mass defect and fragment filtering approach using high resolution mass spectrometry. Molecules. 21(664)2016.PubMed/NCBI View Article : Google Scholar

Wang D, Ge S, Chen Z and Song Y: Evodiamine exerts anticancer effects via induction of apoptosis and autophagy and suppresses the migration and invasion of human colon cancer cells. J BUON. 24:1824–1829. 2019.PubMed/NCBI

Zhu LQ, Zhang L, Zhang J, Chang GL, Liu G, Yu DD, Yu XM, Zhao MS and Ye B: Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota. J Integr Med. 19:56–65. 2021.PubMed/NCBI View Article : Google Scholar

Ogasawara M, Matsubara T and Suzuki H: Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells. Biol Pharm Bull. 24:917–920. 2001.PubMed/NCBI View Article : Google Scholar

Shen H, Zhao S, Xu Z, Zhu L, Han Y and Ye J: Evodiamine inhibits proliferation and induces apoptosis in gastric cancer cells. Oncol Lett. 10:367–371. 2015.PubMed/NCBI View Article : Google Scholar

Hu C, Gao X, Han Y, Guo Q, Zhang K, Liu M, Wang Y and Wang J: Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo. Mol Med Rep. 14:413–419. 2016.PubMed/NCBI View Article : Google Scholar

Huang H, Zhang Y, Liu X, Li Z, Xu W, He S, Huang Y and Zhang H: Acid sphingomyelinase contributes to evodiamine-induced apoptosis in human gastric cancer SGC-7901 cells. DNA Cell Biol. 30:407–412. 2011.PubMed/NCBI View Article : Google Scholar

Sachita K, Kim Y, Yu HJ, Cho SD and Lee JS: In Vitro assessment of the anticancer potential of evodiamine in human oral cancer cell lines. Phytother Res. 29:1145–1151. 2015.PubMed/NCBI View Article : Google Scholar

Wu Y and Wang J, Zhao J, Zhang Y, Sun Y, Chen J and Wang J: Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma. J Cell Biochem. 120:15933–15940. 2019.PubMed/NCBI View Article : Google Scholar

Zhao S, Xu K, Jiang R, Li DY, Guo XX, Zhou P, Tang JF, Li LS, Zeng D, Hu L, et al: Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the hippo-yes-associated protein signaling pathway. Life Sci. 251(117424)2020.PubMed/NCBI View Article : Google Scholar

Hu CY, Wu HT, Su YC, Lin CH, Chang CJ and Wu CL: Evodiamine exerts an anti-hepatocellular carcinoma activity through a WWOX-dependent pathway. Molecules. 22(1175)2017.PubMed/NCBI View Article : Google Scholar

Zhu H, Ge K, Lu J and Jia C: Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME. Naunyn Schmiedebergs Arch Pharmacol. 392:1551–1560. 2019.PubMed/NCBI View Article : Google Scholar

Wang XN, Han X, Xu LN, Yin LH, Xu YW, Qi Y and Peng JY: Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine. 15:1062–1068. 2008.PubMed/NCBI View Article : Google Scholar

Fang C, Zhang J, Qi D, Fan X, Luo J, Liu L and Tan Q: Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells. PLoS One. 9(e115204)2014.PubMed/NCBI View Article : Google Scholar

Wang T, Qi D, Hu X, Li N, Zhang X, Liu H, Zhong C and Zhang J: A novel evodiamine amino derivative as a PI3K/AKT signaling pathway modulator that induces apoptosis in small cell lung cancer cells. Eur J Pharmacol. 906(174215)2021.PubMed/NCBI View Article : Google Scholar

Lin L, Ren L, Wen L, Wang Y and Qi J: Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells. Mol Med Rep. 14:2832–2838. 2016.PubMed/NCBI View Article : Google Scholar

Jiang ZB, Huang JM, Xie YJ, Zhang YZ, Chang C, Lai HL, Wang W, Yao XJ, Fan XX, Wu QB, et al: Evodiamine suppresses non-small cell lung cancer by elevating CD8⁺ T cells and downregulating the MUC1-C/PD-L1 axis. J Exp Clin Cancer Res. 39(249)2020.PubMed/NCBI View Article : Google Scholar

Hong JY, Park SH, Min HY, Park HJ and Lee SK: Anti-proliferative effects of evodiamine in human lung cancer cells. J Cancer Prev. 19:7–13. 2014.PubMed/NCBI View Article : Google Scholar

Tu YJ, Fan X, Yang X, Zhang C and Liang HP: Evodiamine activates autophagy as a cytoprotective response in murine Lewis lung carcinoma cells. Oncol Rep. 29:481–490. 2013.PubMed/NCBI View Article : Google Scholar

Mohan V, Agarwal R and Singh RP: A novel alkaloid, evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells. Biochem Biophys Res Commun. 477:1065–1071. 2016.PubMed/NCBI View Article : Google Scholar

Huang YC, Guh JH and Teng CM: Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci. 75:35–49. 2004.PubMed/NCBI View Article : Google Scholar

Zhang Y, Zhang QH, Wu LJ, Tashiro SI, Onodera S and Ikejima T: Atypical apoptosis in L929 cells induced by evodiamine isolated from evodia rutaecarpa. J Asian Nat Prod Res. 6:19–27. 2004.PubMed/NCBI View Article : Google Scholar

Khan M, Bi Y, Qazi JI, Fan L and Gao H: Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway. Mol Med Rep. 11:257–262. 2015.PubMed/NCBI View Article : Google Scholar

Wu WS, Chien CC, Liu KH, Chen YC and Chiu WT: Evodiamine prevents glioma growth, induces glioblastoma cell apoptosis and cell cycle arrest through JNK activation. Am J Chin Med. 45:879–899. 2017.PubMed/NCBI View Article : Google Scholar

Liu AJ, Wang SH, Chen KC, Kuei HP, Shih YL, Hou SY, Chiu WT, Hsiao SH and Shih CM: Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells. Chem Biol Interact. 205:20–28. 2013.PubMed/NCBI View Article : Google Scholar

Meng ZJ, Wu N, Liu Y, Shu KJ, Zou X, Zhang RX, Pi CJ, He BC, Ke ZY, Chen L, et al: Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling. Oncol Rep. 34:1388–1396. 2015.PubMed/NCBI View Article : Google Scholar

Zhou Y and Hu J: Evodiamine induces apoptosis, G2/M cell cycle arrest, and inhibition of cell migration and invasion in human osteosarcoma cells via Raf/MEK/ERK signalling pathway. Med Sci Monit. 24:5874–5880. 2018.PubMed/NCBI View Article : Google Scholar

Yang S, Chen J, Tan T, Wang N, Huang Y, Wang Y, Yuan X, Zhang P, Luo J and Luo X: Evodiamine exerts anticancer effects against 143B and MG63 cells through the Wnt/β-catenin signaling pathway. Cancer Manag Res. 12:2875–2888. 2020.PubMed/NCBI View Article : Google Scholar

Bai X, Meng H, Ma L and Guo A: Inhibitory effects of evodiamine on human osteosarcoma cell proliferation and apoptosis. Oncol Lett. 9:801–805. 2015.PubMed/NCBI View Article : Google Scholar

Hwang ST, Um JY, Chinnathambi A, Alharbi SA, Narula AS, Namjoshi OA, Blough BE and Ahn KS: Evodiamine mitigates cellular growth and promotes apoptosis by targeting the c-Met pathway in prostate cancer cells. Molecules. 25(1320)2020.PubMed/NCBI View Article : Google Scholar

Zhang T, Qu S, Shi Q, He D and Jin X: Evodiamine induces apoptosis and enhances TRAIL-induced apoptosis in human bladder cancer cells through mTOR/S6K1-mediated downregulation of Mcl-1. Int J Mol Sci. 15:3154–3171. 2014.PubMed/NCBI View Article : Google Scholar

Shi CS, Li JM, Chin CC, Kuo YH, Lee YR and Huang YC: Evodiamine induces cell growth arrest, apoptosis and suppresses tumorigenesis in human urothelial cell carcinoma cells. Anticancer Res. 37:1149–1159. 2017.PubMed/NCBI View Article : Google Scholar

Du J, Sun Y, Lu YY, Lau E, Zhao M, Zhou QM and Su SB: Berberine and evodiamine Act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis. Anticancer Res. 37:6141–6151. 2017.PubMed/NCBI View Article : Google Scholar

Wang KL, Hsia SM, Yeh JY, Cheng SC, Wang PS and Wang SW: Anti-proliferative effects of evodiamine on human breast cancer cells. PLoS One. 8(e67297)2013.PubMed/NCBI View Article : Google Scholar

Du J, Wang XF, Zhou QM, Zhang TL, Lu YY, Zhang H and Su SB: Evodiamine induces apoptosis and inhibits metastasis in MDA-MB-231 human breast cancer cells in vitro and in vivo. Oncol Rep. 30:685–694. 2013.PubMed/NCBI View Article : Google Scholar

Wei L, Jin X, Cao Z and Li W: Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways. J Tradit Chin Med. 36:353–359. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Chen TC, Chien CC, Wu MS and Chen YC: Evodiamine from evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells. Phytomedicine. 23:68–78. 2016.PubMed/NCBI View Article : Google Scholar

Liu N, Li Y, Chen G and Ge K: Evodiamine induces reactive oxygen species-dependent apoptosis and necroptosis in human melanoma A-375 cells. Oncol Lett. 20(121)2020.PubMed/NCBI View Article : Google Scholar

Lin H, Lin L, Choi Y and Michniak-Kohn B: Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma. Int J Pharm. 581(119278)2020.PubMed/NCBI View Article : Google Scholar

Yang J, Wu LJ, Tashiro S, Onodera S and Ikejima T: Nitric oxide activated by p38 and NF-kappaB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells. Free Radic Res. 42:1–11. 2008.PubMed/NCBI View Article : Google Scholar

Wang C, Wang MW, Tashiro S, Onodera S and Ikejima T: Evodiamine induced human melanoma A375-S2 cell death partially through interleukin 1 mediated pathway. Biol Pharm Bull. 28:984–989. 2005.PubMed/NCBI View Article : Google Scholar